A possible benefit from therapeutic anticoagulation in patients with coronavirus disease 2019: the Dolo hospital experience in Veneto, Italy.

Secco, Eleonora; Pasqualetto, Maria Cristina; Bombardini, Tonino; Picano, Eugenio; Rigo, Fausto

Secco, Eleonora; Pasqualetto, Maria Cristina; Bombardini, Tonino; Picano, Eugenio; Rigo, Fausto.

Secco E; Dolo Cardiology, Dolo Hospital, Azienda no. 3 Serenissima, Venice, Italy
Pasqualetto MC; Dolo Cardiology, Dolo Hospital, Azienda no. 3 Serenissima, Venice, Italy
Bombardini T; Faculty of Medicine, University of BanjaLuka, Clinical Center ofThe Republic of Srpska, BanjaLuka, BosniaHerzegovina
Picano E; National Research Council, Institute of Clinical Physiology, Biomedicine Department, Pisa, Italy. picano@ifc.cnr.it
Rigo F; Dolo Cardiology, Dolo Hospital, Azienda no. 3 Serenissima, Venice, Italy

Kardiol Pol ; 78(9): 919-921, 2020 09 25.

Article in English | MEDLINE | ID: covidwho-838322

Subject(s)

Anticoagulants/therapeutic use; Coronavirus Infections/drug therapy; Coronavirus/drug effects; Pneumonia, Viral/drug therapy; Aged; COVID-19; Female; Humans; Italy; Male; Middle Aged; Pandemics; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Coronavirus / Anticoagulants Type of study: Prognostic study Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: Kardiol Pol Year: 2020 Document Type: Article Affiliation country: Kp.15489

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google